1. Home
  2. RVMDW
  3. RVMDW News

Latest Revolution Medicines Inc. Warrant (RVMDW) News on July 26, 2024

MT Newswires

8 days ago

Barclays Adjusts Price Target on Revolution Medicines to $54 From $52, Maintains Overweight Rating

Thomson Reuters StreetEvents

5 months ago

Q4 2023 Revolution Medicines Inc Earnings Call

Associated Press Finance

6 months ago

First Merchants: Q4 Earnings Snapshot

Share on Social Networks: